Jim Tompkins Returns to Tompkins Solutions as Chairman of the Board

RALEIGH, N.C., Oct. 6, 2025 /PRNewswire/ — Tompkins Solutions, a leading warehouse automation consulting and execution firm, is proud to announce the return of its founder, Dr. James A. Tompkins, as Chairman of the Board. Starting in Raleigh, N.C., Dr. Tompkins built Tompkins Solutions into a globally respected supply chain consulting firm, completing over 3,000 projects […]

Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.

STOCKHOLM, Oct. 6, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab-irmb subcutaneous injection (U.S. brand name: Leqembi Iqlik) is now available in the U.S. as a maintenance dosing regimen for the treatment of Alzheimer’s disease (AD) in patients with Mild Cognitive Impairment (MCI) or mild dementia stage of disease […]

K-Diamonds and KPOP DAO Unite to Launch the World’s First Immersive Web3 Fandom Ecosystem for Global K-Culture

SARASOTA, Fla., Oct. 6, 2025 /PRNewswire/ — Official KPOP LLC (“K-Diamonds”), a Delaware limited liability company, today announced a landmark agreement with KPOP DAO LLC ($KPOP), a Wyoming-registered decentralized autonomous organization, to create the world’s first immersive web3 fandom ecosystem dedicated to K-pop and Korean culture. Continue Reading The Official K-Culture Coin The new ecosystem will […]

AOC Gaming Offers Prime Big Deal Days Savings on High-Performance Gaming Monitors

LOS ANGELES, Oct. 6, 2025 /PRNewswire/ — AOC Gaming today announced limited-time discounts on some of its most popular gaming monitors during Amazon’s Prime Big Deal Days on October 7–8.Known for delivering esports-grade performance, AOC’s deals spotlight premium technologies like QD-OLED, Mini-LED, ultra-fast refresh rates, and portable displays designed for gamers on the go. Highlighted […]

W.T.B. Financial Corporation Announces Share Repurchase Authorization

SPOKANE, Wash., Oct. 6, 2025 /PRNewswire/ — W.T.B. Financial Corporation announced today the amendment of its February 28, 2025, share repurchase plan to increase the authorization from $15 million to $30 million of Class B common stock effective through February 28, 2026. Common share repurchases under the new plan, if any, may be made from […]

Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.

STOCKHOLM, Oct. 6, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab-irmb subcutaneous injection (U.S. brand name: Leqembi Iqlik) is now available in the U.S. as a maintenance dosing regimen for the treatment of Alzheimer’s disease (AD) in patients with Mild Cognitive Impairment (MCI) or mild dementia stage of disease […]

Robbins LLP Reminds Cytokinetics, Inc. Investors of the Upcoming Lead Plaintiff Deadline in the Class Action Against CYTK

SAN DIEGO, Oct. 6, 2025 /PRNewswire/ — Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Cytokinetics, Inc. (NASDAQ: CYTK) securities between December 27, 2023 and May 6, 2025. Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class […]